Cargando…

Immunotherapy and radiation for high-grade glioma: a narrative review

Glioblastoma and other high-grade gliomas (HGGs) are the most common and deadly primary brain tumors. Due to recent advances in immunotherapy and improved clinical outcomes in other disease sites, the study of immunotherapy in HGG has increased significantly. Herein, we summarize and evaluate existi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fakhoury, Kareem R., Ney, Douglas E., Ormond, D. Ryan, Rusthoven, Chad G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Review Article on Synergy in Action: Novel Approaches to Combining Radiation Therapy and Immunotherapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797698/ https://www.ncbi.nlm.nih.gov/pubmed/35116570 http://dx.doi.org/10.21037/tcr-20-1933

Ejemplares similares

Narrative review of immunotherapy and radiation therapy in elderly patients
por: Chau, Brittney, et al.
Publicado: (2021)

A narrative review of combining radiation and immunotherapy in gastroesophageal cancers
por: Yoon, Kevin, et al.
Publicado: (2021)

The utilization of immunotherapy with radiation therapy in lung cancer: a narrative review
por: Heinzerling, John H., et al.
Publicado: (2021)

Radiation and immunotherapy: united as one in the fight against cancer
por: Amini, Arya, et al.
Publicado: (2021)

Combinations of immunotherapy and radiation therapy in head and neck squamous cell carcinoma: a narrative review
por: Hayman, Thomas J., et al.
Publicado: (2021)

Narrative review of immune checkpoint inhibitors and radiation therapy for brain metastases
por: Moskalenko, Marina, et al.
Publicado: (2021)

Combination radiation and immunotherapy in gynecologic malignancies—a comprehensive review
por: Ladbury, Colton, et al.
Publicado: (2021)

Efficacy and safety of co‐administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia
por: Jin, Xuan, et al.
Publicado: (2020)

Comparison of efficacy and safety between third‐dose triple and third‐dose dual antihypertensive combination therapies in patients with hypertension
por: Sung, Ki‐Chul, et al.
Publicado: (2023)

Cardiovascular outcomes of β‐blocker—calcium channel blocker initial dual therapy vs. other initial dual therapies in Chinese patients with hypertension: A real‐world retrospective study
por: Lin, Junxiong, et al.
Publicado: (2023)

Age‐specific differences in hypertension combination management and associated factors influencing treatment choice
por: Xiong, Jianfei, et al.
Publicado: (2023)

Toxicity of radiation and immunotherapy combinations
por: Verma, Vivek, et al.
Publicado: (2018)

IMMU-16. INTRA-TUMOURAL IL-12 DELIVERY ENABLES CAR T-CELL IMMUNOTHERAPY FOR HIGH-GRADE GLIOMA
por: Agliardi, Giulia, et al.
Publicado: (2020)

The DNA damage response in immunotherapy and radiation
por: Samstein, Robert M., et al.
Publicado: (2018)

THER-06. THERAPEUTIC EFFICACY OF RRV-MEDIATED PRODRUG ACTIVATOR GENE THERAPY IN CLINICAL TRIALS OF RECURRENT HIGH-GRADE GLIOMA AND IN MURINE ORTHOTOPIC MODELS OF INTRACEREBRAL GLIOMA AND INTRACEREBELLAR MEDULLOBLASTOMA
por: Richardson, Angela, et al.
Publicado: (2020)

Exploring optimal sequencing of radiation and immunotherapy combinations
por: Gunderson, Andrew J., et al.
Publicado: (2018)

Introduction to the special edition on immunotherapy and radiation oncology
por: Bornstein, Sophia, et al.
Publicado: (2018)

Synergizing radiotherapy and immunotherapy: Current challenges and strategies for optimization
por: Rajeev-Kumar, Greeshma, et al.
Publicado: (2022)

Challenges in synergizing radiotherapy with immunotherapy to unlock the abscopal effect in metastatic NSCLC: A systematic review
por: Liu, Jason, et al.
Publicado: (2023)

Neural network based ensemble model to predict radiation induced lymphopenia after concurrent chemo-radiotherapy for non-small cell lung cancer from two institutions
por: Kim, Yejin, et al.
Publicado: (2023)

Role of the immunosuppressive microenvironment in immunotherapy
por: Tormoen, Garth W., et al.
Publicado: (2018)

IMMU-30. UPREGULATED T CELL AND INTERFERON-Γ-RELATED GENE EXPRESSION IS ASSOCIATED WITH INCREASED SURVIVAL IN RECURRENT PEDIATRIC HIGH-GRADE GLIOMA
por: Davidson, Tom, et al.
Publicado: (2020)

THER-07. INHIBITION OF THE RAS SIGNALING ENHANCES VIRAL ONCOLYSIS IN MALIGNANT GLIOMAS
por: Arakawa, Yoshiki, et al.
Publicado: (2020)

IMMU-10. INTERIM ANALYSIS OF THE HIT-HGG REZ IMMUNVAC STUDY - DENDRITIC CELL VACCINATION WITH PARTIAL TREG DEPLETION IN CHILDREN, ADOLESCENTS, AND ADULTS WITH RELAPSED HIGH-GRADE GLIOMAS
por: Eyrich, Matthias, et al.
Publicado: (2020)

IMMU-07. Interim analysis of the HIT-HGG Rez Immunvac study - Dendritic cell vaccination with partial T(reg) depletion and double checkpoint blockade in children with relapsed high-grade gliomas.
por: Eyrich, Matthias, et al.
Publicado: (2022)

THER-09. ONCOLYTIC ADENOVIRUS, DNX-2401, FOR NAIVE DIFFUSE INTRINSIC PONTINE GLIOMAS: A PHASE I CLINICAL TRIAL
por: Iñigo-Marco, Ignacio, et al.
Publicado: (2020)

IMMU-13. Dual CTLA4/ PD-1 blockade improves survival for replication-repair deficient high-grade gliomas failing single agent PD-1 inhibition: An IRRDC study
por: Das, Anirban, et al.
Publicado: (2022)

IMMU-22. PHASE IB IMMUNOTHERAPY CLINICAL TRIAL WITH THE USE OF AUTOLOGOUS DENDRITIC CELLS PULSED WITH AN ALLOGENIC TUMORAL CELL LINES LYSATE IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
por: Madrid, Andres Morales La, et al.
Publicado: (2020)

THER-05. GENETICALLY STABLE POLIOVIRUS VECTOR CARRYING H3.3K27M ANTIGEN FOR TREATMENT OF DIFFUSE MIDLINE GLIOMA BY INTRAMUSCULAR INJECTION
por: Mosaheb, Mubeen, et al.
Publicado: (2020)

Engineering CAR-NK cells: how to tune innate killer cells for cancer immunotherapy
por: Schmidt, Dayane, et al.
Publicado: (2022)

Generating antitumor immunity by targeted radiation therapy: Role of dose and fractionation
por: Ko, Eric C., et al.
Publicado: (2018)

Does Combined Fractionated Stereotactic Radiotherapy and Immunotherapy Change the Outcome of Recurrent High-Grade Gliomas?
por: Yuce Sari, Sezin, et al.
Publicado: (2021)

Progress in Guillain–Barré syndrome immunotherapy—A narrative review of new strategies in recent years
por: Yao, Jiajia, et al.
Publicado: (2023)

Post-irradiation intratumoral heterogeneity modulates response to immune checkpoint inhibition therapy in a murine melanoma model
por: Wang, Jie, et al.
Publicado: (2022)

Identification and characterization of circular RNAs as novel putative biomarkers to predict anti-PD-1 monotherapy response in metastatic melanoma patients – Knowledge from two independent international studies
por: Zhou, Jian-Guo, et al.
Publicado: (2023)

Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes
por: Tatovic, D, et al.
Publicado: (2022)

IMMU-14. SynNotch chimeric antigen receptor (CAR) T-cells as a potential treatment for diffuse intrinsic pontine glioma (DIPG)/diffuse midline glioma (DMG)
por: Ferrerosa, Lauren, et al.
Publicado: (2022)

Systemic cellular viroimmunotherapy for canine high-grade gliomas
por: Cloquell, Ana, et al.
Publicado: (2022)

Three-dimensional printing in ophthalmology and eye care: current applications and future developments
por: Fakhoury, Yazan, et al.
Publicado: (2022)

Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors
por: Ellsworth, Susannah G.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jnsk0p2cmio9dkhtutih8ct4hf